At a glance
- Originator Eli Lilly and Company
- Class Acetophenones; Antiasthmatics; Small molecules
- Mechanism of Action Leukotriene receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 30 Jul 2002 No development reported - Phase-I for Asthma (unspecified route)